Net clinical benefit analysis of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and chronic kidney disease
Open Access
- 1 June 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Medicine
- Vol. 98 (26) , e16194
Abstract
Background: Atrial fibrillation (AF) is increasingly prevalent in chronic kidney disease (CKD) patients. The efficacy and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in AF and CKD patients remains unknown. This systematic review and meta-analysis will mainly assess net clinical benefit (NCB) property of NOACs versus warfarin in patients with AF and CKD by a pooled-analysis. Methods: We will search Medline, Embase, Cochrane Library, and Clinical Trials.gov Website comprehensively for eligible randomized controlled trials that report the efficacy and safety outcomes according to renal function of NOACs. Relative risks and their 95% confidence intervals will be calculated using fixed- and random-effects models. Subgroup, sensitivity, and regression analyses will be performed to evaluate intertrial heterogeneity and bias of the results. NCB that balance stroke/systemic embolism (SSE) and major bleeding will be calculated using Singer's method. Results: This systemic review and meta-analysis will evaluate the NCB of NOACs versus warfarin via SSE, major bleeding and all-cause death in patients with CKD. Conclusions: This study will provide new evidence for clinical profile of NOACs on SSE, major bleeding, all-cause death, and NCB in CKD patients. PROSPERO registration number: CRD42019116940.Keywords
This publication has 28 references indexed in Scilit:
- Renal function and non-vitamin K oral anticoagulants in comparison with warfarin on safety and efficacy outcomes in atrial fibrillation patients: a systemic review and meta-regression analysisClinical Research in Cardiology, 2014
- Patterns of Initiation of Oral Anticoagulants in Patients with Atrial Fibrillation— Quality and Cost ImplicationsThe American Journal of Medicine, 2014
- Novel Oral Anticoagulants in Patients With Renal Insufficiency: A Meta-analysis of Randomized TrialsCanadian Journal of Cardiology, 2014
- Net Clinical Benefit of Rivaroxaban versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation: A Subgroup Analysis of J-ROCKET AFJournal of Stroke and Cerebrovascular Diseases, 2014
- Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial FibrillationCirculation, 2014
- Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on WarfarinChest, 2013
- Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trialEuropean Heart Journal, 2012
- Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney DiseaseNew England Journal of Medicine, 2012
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairmentEuropean Heart Journal, 2011
- Chronic Kidney Disease Is Associated With the Incidence of Atrial FibrillationCirculation, 2011